Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Evangelos Terpos, MD PhD, Despina Fotiou, MD, Konstantinos Anargyrou, MD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Christoulas, MD, Polyzois Makras, MD PhD, Maria Dimou, MD PhD, Ioannis Ntanasis-Stathopoulos, MD, Stavroula Masouridou, MD, Maria K. Angelopoulou, MD, Athanasios Papatheodorou, PhD, Konstantinos Tsionos, MD, Panayiotis Panayiotidis, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4124.

https://doi.org/10.1182/blood-2019-123615

Published: 2019

Journal Articles

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study

Blood (2011) 118 (21): 4446.

https://doi.org/10.1182/blood.V118.21.4446.4446

Published: 2011

Journal Articles

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Konstantinos Anargyrou, Theodoros P. Vassilakopoulos, Konstantinos Tsionos, Panayiotis Kokkoris, Georgios Boutsikas, Maria K. Angelopoulou, Dimitrios Christoulas, Stavroula Masouridou, Maria Dimou, Athanasios Papatheodorou, Danos N. Chatzifotiadis, Panayiotis Panayiotidis, Gerasimos A. Pangalis, Photis Beris, Evangelos Terpos

Blood (2010) 116 (21): 5071.

https://doi.org/10.1182/blood.V116.21.5071.5071

Published: 2010

Journal Articles

First-Line Chemotherapy Leads to High Bone Turnover and Reduced Bone Mass in Patients with Non-Hodgkin's Lymphoma (NHL).

Blood (2009) 114 (22): 1951.

https://doi.org/10.1182/blood.V114.22.1951.1951

Published: 2009

Journal Articles

CD4(+)/CD56(+) Hematodermic (plasmacytoid dendritic cell) Tumor: a Highly Proliferating Neoplasm with Aberrant Expression of Immunohistochemical Markers and Poor Outcome.

Marina Siakantaris, M.D., George Rassidakis, MD, PhD, Flora Kontopidou, MD, Aglaia Dimitrakopoulou, MD, Theodoros Vassilakopoulos, MD, Maria K. Angelopoulou, Styliani Kokkoris, MD, Nikolaos Evangelatos, MD, Konstantinos Anargyrou, MD, Othon Michail, MD, Penelope Korkolopoulou, MD, G.A. Pangalis

Blood (2009) 114 (22): 2930.

https://doi.org/10.1182/blood.V114.22.2930.2930

Published: 2009

Journal Articles

Increased Levels of Serum Tissue Inhibitor of Metalloproteinase-1 Correlate with Advanced Stage, Increased Bone Resorption, Lytic Bone Disease and Poor Survival in Newly-Diagnosed Myeloma Patients

Evangelos Terpos, Meletios A. Dimopoulos, Vikas Shrivastava, Kim Leitzel, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Konstantinos Anargyrou, Efstathios Kastritis, Allan Lipton

Blood (2008) 112 (11): 5143.

https://doi.org/10.1182/blood.V112.11.5143.5143

Published: 2008

Journal Articles

The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.

Meletios A. Dimopoulos, Konstantinos Anargyrou, Eirini Katodritou, Efstathios Kastritis, Anastasia Pouli, Evridiki Michali, Evgenia Verrou, Anastasia Banti, Konstantinos Tsionos, Aikaterini Stefanoudaki, Konstantinos Zervas, Evangelos Terpos

Blood (2007) 110 (11): 1478.

https://doi.org/10.1182/blood.V110.11.1478.1478

Published: 2007

Journal Articles

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

Blood (2007) 110 (11): 1490.

https://doi.org/10.1182/blood.V110.11.1490.1490

Published: 2007

Journal Articles

The Combination of Bortezomib, Doxorubicin, and Dexamethasone (PAD) Is an Effective Regimen for High Risk, Newly Diagnosed, Patients with Multiple Myeloma, Reduces Bone Resorption and Normalizes Angiopoietin-1 to Angiopoietin-2 Ratio.

Evangelos Terpos, Sosana Delimpasi, Konstantinos Anargyrou, Ioannis Baltathakis, Efstathios Kastritis, Anna Christoforidou, Konstantinos Tsionos, Konstantinos Tsatalas, Emmanuel Nikiforakis, Meletios A. Dimopoulos, Nikolaos Harhalakis

Blood (2007) 110 (11): 3596.

https://doi.org/10.1182/blood.V110.11.3596.3596

Published: 2007

Journal Articles

High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.

Efstathios Kastritis, MD, Evangelos Terpos, MD, Mihail Mihail, MD, Konstantinos Anargyrou, MD, Sossana Delimpassi, MD, Marie Christine Kyrtsonis, MD, Evridiki Mihali, MD, Elina Vervessou, MD, Natalia Tzenou, MD, Panagiotis Repoussis, MD, Gerassimos Panagalis, MD, Meletios Athanasios Dimopoulos, MD

Blood (2007) 110 (11): 4781.

https://doi.org/10.1182/blood.V110.11.4781.4781

Published: 2007

Journal Articles

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Sotirios Sachanas, Maria K. Angelopoulou, Konstantinos Anargyrou, Styliani I. Kokoris, Theodoros P. Vassilakopoulos, Zacharoula I. Galani, Evangelia M. Dimitriadou, Marina P. Siakantaris, Maria N. Dimopoulou, Flora N. Kontopidou, Marie-Christine Kyrtsonis, Eleni Plata, Panayiotis Tsaftaridis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4718.

https://doi.org/10.1182/blood.V108.11.4718.4718

Published: 2006

Journal Articles

Efficacy of Rituximab in Hairy Cell Leukemia.

Styliani I. Kokoris, Maria K. Angelopoulou, Zacharoula I. Galani, Konstantinos Anargyrou, Sotirios Sachanas, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Flora N. Kontopidou, Evangelia M. Dimitriadou, Maria N. Dimopoulou, Panayiotis Tsaftaridis, Eleni Plata, Christina Kalpadakis, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Gerassimos A. Pangalis

Blood (2006) 108 (11): 4719.

https://doi.org/10.1182/blood.V108.11.4719.4719

Published: 2006

NARROW

Bone Loss and High Bone Turnover in Patients with Non-Hodgkin's Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study

Low Bone Mineral Density and High Bone Turnover In Patients with Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

First-Line Chemotherapy Leads to High Bone Turnover and Reduced Bone Mass in Patients with Non-Hodgkin's Lymphoma (NHL).

CD4(+)/CD56(+) Hematodermic (plasmacytoid dendritic cell) Tumor: a Highly Proliferating Neoplasm with Aberrant Expression of Immunohistochemical Markers and Poor Outcome.

Increased Levels of Serum Tissue Inhibitor of Metalloproteinase-1 Correlate with Advanced Stage, Increased Bone Resorption, Lytic Bone Disease and Poor Survival in Newly-Diagnosed Myeloma Patients

The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.

The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).

The Combination of Bortezomib, Doxorubicin, and Dexamethasone (PAD) Is an Effective Regimen for High Risk, Newly Diagnosed, Patients with Multiple Myeloma, Reduces Bone Resorption and Normalizes Angiopoietin-1 to Angiopoietin-2 Ratio.

High Serum Levels of Angiogenic Cytokines in AL Amyloidosis Correlates with Disease Features.

Long Term Follow up of Hairy Cell Leukemia (HCL) Patients (PTS) Treated with Interferon-Alpha (IFN-α). The Importance of Maintenance.

Efficacy of Rituximab in Hairy Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only